ArticleFrontiers in medicine2025
Triglyceride-glucose index is associated with lupus nephritis and gender disparity in systemic lupus erythematosus patients.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between the CRP-TyG index and lupus nephritis risk.Biomolecules & biomedicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Recent studies investigated that triglyceride glucose (TyG) index and triglyceride (TG) are associated with an elevated likelihood of developing and worsening chronic kidney disease (CKD). We aimed to evaluate the correlation between the TyG index and TG with lupus nephritis (LN), respectively, and explore its value in monitoring LN. Methods: 1,192 Systemic Lupus Erythematosus (SLE) patients were involved in this cross-sectional investigation. The presence or absence of LN was used to divide the individuals involved into two distinct categories. Multivariate logistic regression, restricted cubic spline, and subgroup analyses were applied to explore the connection between the TyG index and TG with LN, respectively. Results: According to the study, the TyG index and TG were dose-dependently positively correlated with LN. After accounting for additional factors, each standard deviation of an upsurge in the TyG index and TG corresponded to a higher risk for LN by 36.4 and 34%, respectively. Besides, the adjusted ORs (with 95% CIs) for LN were precisely 1.625 (1.097, 2.405) and 1.756 (1.193, 2.585) when comparing the highest tertile to the lowest tertile of the TyG index and TG, respectively. Additionally, both TyG index and TG were significantly positively correlated with LN in age and body mass index (BMI) subgroups, and these two indicators were independently associated with LN in female SLE patients but not in male SLE patients, respectively. Conclusion: Both the elevated TyG index and TG were linked to LN on their own and gender disparity in SLE patients, which suggests that the TyG index and TG could be beneficial in the early screening for those with LN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.